Dr Phil Shackley |
HEDS and
ScHARR has huge global esteem as a research and teaching centre, what is it
that makes HEDS so successful?
In short,
the people who work here. We are lucky
to have such fantastic staff who are tremendously committed to what we do in
terms of our research, teaching and our other activities. There’s a great sense of togetherness and a willingness
to help one another out whenever the occasion demands.
You have
taken over from Professor Simon Dixon who has been the Director of HEDS for six
years, what advice has Simon given to you?
Simon’s
main advice was to rein in any megalomaniac tendencies I may have and not to
take on too much myself! The art of
delegation is one I intend to practise.
You have
had two stints with ScHARR starting way back in 1996, what changes have you
seen in your field of health economics in that time?
Where to
begin? If I had to pick one, it would be
the increased sophistication of the methods of cost-effectiveness
analysis. This is due in no small part
to the now extensive use of Bayesian methods to examine uncertainty in economic
evaluations. Back in 1996, I had no idea
what a probabilistic sensitivity analysis was!
Teaching
has played a large part of your role in recent years, will that continue or are
you keen to move back towards research and your own specialist research areas?
The big
change will be finally relinquishing my teaching management roles. As well as being the Section Director for
Learning and Teaching and a long serving member of the School’s Teaching
Committee, I’ve also served time as programme director for two of our Masters
courses (most recently the MSc Heath Economics and Decision Modelling, and in
the dim and distant past the MSc in Health Economics and Management). As far as my teaching is concerned, I’ve always
enjoyed that aspect of my job, and I have no plans to stop doing it in the
foreseeable future.
What are
your plans for the short term?
To hold
onto my sanity! Only kidding! To build on the strong foundations provided by my
predecessors (Simon Dixon and Alan Brennan) to consolidate (and hopefully
strengthen) our position as one of the world’s leading centres for health economics
and decision science.